Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (11 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net sales
97
204
204
205
205
228
201
Cost of sales
75
125
124
122
122
134
124
Gross Profit
22
79
81
83
83
94
77
Selling, engineering and administrative expenses
20
24
26
27
27
30
30
Operating Income
2
55
54
56
56
64
47
Interest (income) expense, net
-1
-1
-1
-1
-1
-2
-1
Foreign currency transaction (gain) loss, net
0
0
0
0
0
-1
-1
Miscellaneous (income) expense, net
0
-1
0
0
0
1
0
Income before income taxes
2
58
56
57
57
66
49
Income tax provision
0
20
18
19
19
22
16
Net income
2
38
37
38
38
44
33
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 7, 2014 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 1, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (31 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash and cash equivalents
n/a
43
34
55
57
57
82
Restricted cash
n/a
0
0
0
0
0
0
Accounts receivable, net of allowance for doubtful accounts of $184 and $172
n/a
16
14
17
18
18
14
Inventories
n/a
13
13
14
14
14
13
Income taxes receivable
n/a
0
1
1
0
0
0
Deferred income taxes
n/a
0
0
0
0
0
0
Marketable securities
n/a
30
0
0
0
0
0
Short-term investments
n/a
0
38
39
43
43
44
Other current assets
n/a
1
3
3
3
3
4
Total current assets
n/a
104
102
129
136
136
157
Property, plant and equipment, net
n/a
57
65
76
78
78
74
Goodwill
n/a
0
4
5
5
5
5
Other assets
n/a
7
4
3
4
4
5
Total assets
n/a
168
175
213
223
223
242
Liabilities and owners' equity
Accounts payable
n/a
4 4402000
5 4606000
5 4630000
5 4873000
5 4873000
4 4422000
Accrued expenses and other liabilities
n/a
7 7466000
8 7641000
7 7016000
8 7908000
8 7908000
5 4849000
Taxes Payable, Current
n/a
0 0
0 0
0 0
1 559000
1 559000
0 0
Dividends payable
n/a
2 2318000
0 0
2 2372000
2 2392000
2 2392000
2 2411000
Total current liabilities
n/a
14 14186000
12 12247000
14 14018000
16 15732000
16 15732000
12 11682000
Deferred income taxes
n/a
7 6917000
7 7230000
8 7747000
9 8501000
9 8501000
7 7411000
Other noncurrent liabilities
n/a
1 1149000
0 371000
0 285000
0 272000
0 272000
0 260000
Total liabilities
n/a
22 22252000
20 19848000
22 22050000
25 24505000
25 24505000
19 19353000
Commitments and contingencies
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Preferred stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Common stock
n/a
0 26000
0 26000
0 26000
0 27000
0 27000
0 27000
Capital in excess of par value
n/a
49 48944000
57 57402000
65 65391000
73 73499000
73 73499000
82 82265000
Retained earnings
n/a
98 98426000
97 97242000
123 123420000
129 128818000
129 128818000
150 149938000
Accumulated other comprehensive income (loss)
n/a
-2 -2120000
1 603000
3 2591000
-4 -4085000
-4 -4085000
-10 -10043000
Total shareholders’ equity
n/a
145 145276000
155 155273000
191 191428000
198 198259000
198 198259000
222 222187000
Total liabilities and shareholders’ equity
n/a
168 167528000
175 175121000
213 213478000
223 222764000
223 222764000
242 241540000
Remarks restated on n/a restated on Mar 12, 2013 n/a restated on Mar 7, 2014 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (38 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net income
2
38
37
38
38
44
33
Depreciation and amortization
7
7
7
7
7
9
10
(Gain)Loss on disposal of assets
0
0
0
0
0
0
0
Gain on investment in business
0
-1
0
-1
-1
0
0
Stock compensation income tax benefit
1
2
2
3
3
4
4
Deferred director and phantom stock unit expense (income)
0
0
0
0
0
0
0
Stock compensation income tax benefit
0
0
0
0
0
0
0
Deferred director and phantom stock unit expense (income)
0
0
0
0
0
0
0
Provision for slow moving inventory
0
0
0
0
0
0
0
Provision for deferred income taxes
0
1
0
0
0
1
-1
Accounts receivable
3
1
2
-3
-3
-1
4
Inventories
2
-2
0
-1
-1
0
1
Income taxes receivable
0
1
-1
0
0
1
0
Other current assets
-1
-1
-1
0
0
0
-1
Other assets
1
-1
0
0
0
0
0
Accounts payable
-1
0
-1
0
0
0
0
Accrued expenses and other liabilities
-1
4
5
3
3
4
0
Increase (decrease) in income taxes payable
0
0
0
0
0
1
-1
Other noncurrent liabilities
0
0
0
0
0
0
0
Net cash provided by operating activities
14
50
52
47
47
63
50
Proceeds from sale of joint venture
0
1
0
0
0
0
0
Investment in business, net of cash acquired
0
-2
-1
-1
-1
0
0
Payments to Acquire Intangible Assets
0
0
0
0
0
-1
-1
Capital expenditures
-5
-10
-13
-18
-18
-11
-6
Proceeds from dispositions of equipment
0
0
0
0
0
0
2
Purchases of short-term investments
-11
-27
-40
-28
-28
-51
-30
Proceeds from Sale of Short-term Investments
3
8
33
27
27
45
27
Net cash used in investing activities
-13
-30
-22
-20
-20
-18
-9
Repayment of debt
0
0
0
0
0
0
0
Stock compensation income tax benefit
0
0
0
0
0
0
0
Stock compensation income tax benefit
0
0
0
0
0
0
0
Proceeds from stock issued
0
1
1
1
1
1
1
Dividends to shareholders
-8
-10
-41
-9
-9
-38
-12
Change in restricted cash
0
0
0
0
0
0
0
Net cash used in financing activities
-7
-9
-41
-8
8
37
11
Effect of exchange rate changes on cash and cash equivalents
2
-1
2
2
2
-5
-5
Net increase (decrease) in cash and cash equivalents
-5
10
-8
20
20
2
25
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 7, 2014 n/a
calculated values,
restated on Feb 24, 2015 n/a
calculated values,
restated on Feb 24, 2015 n/a
calculated values,
restated on Mar 1, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Sumo